Furthermore, our analysis revealed that mutations in tumor-related pathways within the high- and low-risk groups were primarily clustered in MYC, RTK-RAS, TGF-Beta, and Cell_Cycle pathways (Figure 4d). The gene discussed is MYC; the disease is neoplasm.